For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

Labroots is excited to announce our 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 held on May 14th, 2025! The Precision Medicine: Genomics, ...

Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...

Drugs like Ozempic and Wegovy can have a surprising impact on the brain, suggesting potential new avenues of research and ...

Molecular Sciences, researchers at the University of Mississippi center found that cinnamaldehyde – a primary component of cinnamon – activates receptors that control the metabolic clearance of ...

The multi-year agreement will completely utilise Translational360, a recently introduced integrated research-grade longitudinal clinical molecular database. This database incorporates de-identified ...

"We are fortunate to have timed this release during industry downturn and economic challenges alongside the disruption to non-invasive body contouring demand by that of semaglutide and the heavily ...

Now a study published in Ecotoxicology and Environmental Safety has found that in yet another part of the body, which researchers say “should serve as an important warning signal.” Luigi ...